Ultragenyx Pharmaceutical: Q4 Earnings Insights

Ultragenyx Pharmaceutical RARE reported its Q4 earnings results on Thursday, February 10, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Ultragenyx Pharmaceutical missed estimated earnings by 33.58%, reporting an EPS of $-1.79 versus an estimate of $-1.34.

Revenue was up $8.15 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.33, which was followed by a 1.38% increase in the share price the next day.

Here's a look at Ultragenyx Pharmaceutical's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.